AI Governance Cannot Stop at Approval
September 27, 2026
Streamline retail operations for enhanced business performance & improved guest services.
Streamline retail operations for enhanced business performance & improved guest services.
Delivering seamless user experiences in the IT sector through our managed solutions.
Delivering seamless user experiences in the IT sector through our managed solutions.
Smart IMS proudly receives the Good Employer Charter 2024, pledging to uphold exceptional human resource practices and empower our team—recognized by the Labor Department of Japan
Smart IMS proudly receives the Good Employer Charter 2024, pledging to uphold exceptional human resource practices and empower our team—recognized by the Labor Department of Japan
What Is Computer System Validation (CSV)?
Computer System Validation (CSV) is the documented process of ensuring that a computerized system consistently performs as intended according to predetermined specifications and quality standards. In regulated life sciences environments — including pharmaceutical, biotech, and medical device industries — CSV is a regulatory mandate, not a choice.
Years in Life Sciences IT
~
0
+
GxP Systems Validated Globally
~
0
+
Regulatory Frameworks We Support
FDA 21 CFR Part 11
GAMP 5
EU GMP Annex 11
ICH Q10
PICS GMP Guidance
21 CFR Part 820
ISO 13485
FDA CSA Guidance 2022
FDA 21 CFR Part 11
EU GMP Annex 11
GAMP 5
PICS GMP Guidance
ICH Q10
FDA CSA Guidance 2022
ISO 13485
21 CFR Part 820
Our Computer System Validation Services
Smart IMS delivers end-to-end CSV and CSA services across the full spectrum of GxP computerized systems in pharma, biotech, clinical research, and medical devices. Our specialists are experienced in validating both COTS applications and custom-developed platforms.
Laboratory Equipment Systems Validation
Comprehensive qualification services (IQ/OQ/PQ) for laboratory instruments and LIMS platforms, including method validation and ongoing calibration management to ensure data accuracy and regulatory reliability.
Quality Management Systems (QMS)
GxP-compliant QMS validation covering document control, audit management, deviation handling, and CAPA workflows. We configure and validate systems that meet FDA and EMA expectations for pharmaceutical quality systems under ICH Q10.
Manufacturing Execution Systems (MES)
End-to-end MES validation enabling real-time batch monitoring, electronic batch records (EBR), and manufacturing data integrity. We ensure your MES meets 21 CFR Part 11 and Annex 11 requirements across the production lifecycle.
Electronic Document Management (EDMS)
Validation of EDMS platforms covering system configuration, data migration, user access controls, and audit trail verification. We ensure electronic records and signatures comply fully with 21 CFR Part 11 and EU Annex 11 standards.
GxP Validated Clinical Data Cloud Systems
Validation of cloud-hosted clinical data platforms (SaaS/PaaS), including vendor qualification, shared responsibility assessments, and data migration validation. Fully aligned with FDA cloud computing guidance and EU Annex 11 remote data storage requirements.
Data Integrity & ALCOA+ Compliance
Comprehensive data integrity programs covering governance policies, validation protocols, gap assessments, and remediation. We ensure your data management practices fully satisfy ALCOA+ principles and withstand FDA/EMA data integrity inspections.
Facility Automation Management Systems
Validation of Building Management Systems (BMS) and Facility Automation controls for GxP-regulated environments. We qualify environmental monitoring systems, HVAC controls, and clean utility systems to regulatory and operational standards.
Automation Testing for CSV
Automated test execution frameworks for GxP systems that dramatically reduce validation cycle times while maintaining test coverage and traceability. Our test automation solutions integrate with your existing ALM and validation lifecycle management tools.
Mock Audit & QA Consulting Services
Pre-inspection readiness assessments and mock FDA/EMA audit simulations focused on CSV compliance. We identify compliance gaps, remediate findings, and prepare your team for regulatory inspections with confidence.
Client Speak
Our Risk-Based CSV Methodology
Smart IMS applies a structured, risk-based validation methodology aligned with GAMP 5, FDA CSA guidance, and EU Annex 11 expectations — balancing compliance rigor with operational efficiency.
System Inventory & Risk Assessment
We catalogue your GxP computerized systems, classify them under GAMP 5 categories, and perform a risk assessment to determine the required level of validation effort based on patient risk and business impact.
Validation Strategy & Planning
We develop a Validation Master Plan (VMP) and system-specific Validation Plans defining scope, approach, responsibilities, acceptance criteria, and deliverables — approved by your QA and regulatory teams.
Requirements & Design Documentation
We produce or review User Requirements Specifications (URS), Functional Specifications (FS), and Design Specifications (DS) to establish a clear, traceable baseline for the system's intended use.
IQ / OQ / PQ Execution
We execute Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) protocols — with full traceability to requirements and deviations managed through your CAPA process.
Validation Summary & Continued Compliance
We compile the complete validation package, issue a Validation Summary Report, and establish change control and periodic review procedures to maintain the system's validated state throughout its operational lifecycle.
Why Smart IMS for CSV?
We are committed to providing our clients with the highest quality QA services possible that meet your business objectives and exceed industry expectations.
25+ years of domain expertise
Our team holds deep experience across pharma, biotech, CRO, and medical device sectors, with in-depth knowledge of FDA, EMA, and PICS regulatory environments.
COTS and custom system expertise
We validate commercially off-the-shelf (COTS) applications including SAP, Veeva, IQVIA, and custom-built platforms with equal confidence.
100% inspection pass rate
Our CSV deliverables have successfully withstood FDA, EMA, and PICS regulatory inspections, giving clients confidence at the highest-stakes moments.
GAMP 5 & CSA certified specialists
All project leads are certified in GAMP 5 methodology and current FDA CSA guidance, ensuring your validation packages are future-proof.
Global reach, local knowledge
With teams across North America, Europe, and APAC, we understand the regulatory nuances of each jurisdiction without adding coordination overhead.
Get Insights on Transition from CSV to CSA in Our Whitepaper!
FAQ's
What is the difference between CSV and CSA?
CSV (Computer System Validation) is the traditional, documentation-intensive approach requiring comprehensive lifecycle evidence. CSA (Computer Software Assurance) is the FDA’s newer approach from 2022 that replaces documentation volume with critical thinking and risk-based testing. CSA allows organizations to focus validation effort on what genuinely impacts patient safety, significantly reducing the time and cost of validation. Smart IMS supports both and can guide your transition from CSV to CSA.
Which computer systems require GxP validation in life sciences?
Any computerized system used in a GxP-regulated environment that creates, modifies, maintains, archives, retrieves, or transmits electronic records requires validation. This includes: LIMS (Laboratory Information Management Systems), ERP systems used in manufacturing, MES (Manufacturing Execution Systems), EDMS/DMS, clinical trial management systems (CTMS), pharmacovigilance systems, process control and automation systems, and quality management systems (QMS). The level of validation required depends on the system’s GAMP 5 risk category and its impact on product quality and patient safety.
How long does computer system validation take?
Timelines vary significantly based on system complexity and GAMP 5 category. Simple infrastructure or COTS tools (Category 1–3) typically require 4–8 weeks. Configured commercial systems (Category 4) such as SAP or Veeva may take 3–6 months. Complex custom-built systems (Category 5) can require 6–18 months. Smart IMS uses automation testing and templates to compress timelines while maintaining documentation quality and regulatory defensibility.
What regulations govern computer system validation in pharma?
The primary regulatory frameworks are: FDA 21 CFR Part 11 (US — electronic records and signatures), EU GMP Annex 11 (EU/EEA — computerized systems in manufacturing), GAMP 5 (global industry best practice from ISPE), PICS GMP guidance (global harmonized standards), ICH Q10 (pharmaceutical quality systems), and FDA’s 2022 Computer Software Assurance (CSA) guidance. For medical devices, 21 CFR Part 820 and ISO 13485 also apply. Smart IMS has deep expertise across all of these frameworks.
How do you ensure the security of our software during testing?
The primary regulatory frameworks are: FDA 21 CFR Part 11 (US — electronic records and signatures), EU GMP Annex 11 (EU/EEA — computerized systems in manufacturing), GAMP 5 (global industry best practice from ISPE), PICS GMP guidance (global harmonized standards), ICH Q10 (pharmaceutical quality systems), and FDA’s 2022 Computer Software Assurance (CSA) guidance. For medical devices, 21 CFR Part 820 and ISO 13485 also apply. Smart IMS has deep expertise across all of these frameworks.
Can Smart IMS validate cloud-based or SaaS systems?
Yes. Smart IMS offers specialized GxP cloud validation services for SaaS and cloud-hosted platforms. We conduct vendor qualification assessments, review shared responsibility matrices, validate data migration, and ensure the system architecture complies with FDA cloud guidance and EU Annex 11 requirements for remote data storage. We have experience validating systems on AWS, Azure, and GCP infrastructure used for GxP purposes.
What happens if a validated system is changed or upgraded?
Any change to a validated system — including software upgrades, configuration changes, hardware modifications, or operating environment changes — must go through a formal Change Control process. A change impact assessment determines whether partial or full revalidation is required. Smart IMS provides ongoing change control support and periodic review services to keep your systems in a continuously validated state, avoiding compliance gaps that frequently arise from unmanaged system changes.
Does Smart IMS provide CSV training for internal teams?
Yes. Smart IMS offers structured CSV training programs for quality, IT, and validation teams covering GAMP 5 methodology, 21 CFR Part 11 requirements, FDA CSA guidance, data integrity principles, and practical protocol writing. Our training has received strong feedback from clients including Interchemie Werken De Adelaar, where the program significantly improved the team’s validation knowledge and process confidence.
What’s New at Smart IMS?
Find some of our latest customer success stories, company updates and wins, and our thoughts on the latest industry developments right here.
Meet Our Industry Leaders
Executive Vice President – Life Sciences & EAM
Director
Director
Get in Touch
Connect with us to learn more on how to optimize your business through our transformational enterprise solutions and services.
Get a Deep Dive into CSV to CSA
Dr. Rahul Srivastava is responsible for Strategy, execution, and P&L for the Life Sciences portfolio at Smart IMS, focusing on technology solutions and services for CROs, AROs, Pharma, life sciences, and regulators.
Dr. Srivastava is coming with over 25 years of experience in technology implementation in life sciences and dental sciences. As a thought leader, he carries a business-oriented consulting experience to help the client in the process re-engineering and building cost-sensitive and robust technology solutions.
Dr. Srivastava has been a part of various IT governance and steering committees involving CIOs and CTOs of client organizations to advise on product strategy, and IT TCO analysis for capital budgeting, planning, governance, and partnership selection.
Dr. Ritesh has over 19 years of experience working with CRO, Healthcare IT, BPO and Government Organizations. He is leading the development of the Life Sciences Product portfolio and solutions.
Dr. Ritesh comes with a blend of technology and Domain expertise and has worked on various functions including Service Delivery Operations and Subject Matter expertise for Pharmacovigilance, Clinical Data Management and Healthcare Product development. Ritesh also comes with experience of implementation of Electronic Health Record Application and providing leadership for implementation of Government schemes at State level.
Dr. Alex Philip is a Technologist and Product Strategist with extensive expertise in Lifesciences – Clinical Trials, and Healthcare, in both the Providers and Payers space.
He is a trained Physician with prior clinical experience and has nearly two decades of experience in developing solutions for Clinical Operations, Clinical Data Management, Electronic Trial Master Files, Electronic Health Records, and Payer Systems. As a subject matter expert, he has executed several successful product strategies to develop solutions that meet customer needs and drive business growth.
Dr. Philip is passionate about leveraging technology to improve patient outcomes and has specific expertise in Healthcare Interoperability and Systems Integration. With his strong background in Product Development, Product Design, Technical Architecture, and Business Analysis, he is well-versed in identifying and implementing emerging technology trends and their potential impact on the market.
Dr. Philip’s unique blend of medical expertise and technology allows him to innovate and improve healthcare delivery.